Literature DB >> 3875690

Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus.

J Ernerudh, T Olsson, F Lindström, T Skogh.   

Abstract

Central nervous system (CNS) involvement is a common and important complication in systemic lupus erythematosus. The mechanisms for CNS involvement are poorly understood and reliable diagnostic procedures are lacking. Pairs of serum and cerebrospinal fluid (CSF) specimens from 17 patients with clinical and serological manifestations of systemic lupus erythematosus were analysed. All 11 patients with definite or suspect clinical CNS disorder revealed some kind of abnormality in the CSF, in contrast to three of seven systemic lupus erythematosus patients without CNS disorder. The most prominent findings in systemic lupus erythematosus patients with CNS disorder were immune aberrations with oligoclonal bands on agarose isoelectric focusing (AIF) and elevation of IgG and IgM index, probably reflecting intrathecal production of IgG and IgM respectively. Intrathecal production of antiviral antibodies was found in four of 12 patients by AIF followed by immunofixation and subsequent autoradiography. An enzyme-linked immunoabsorbent assay (ELISA) could not detect autoantibodies against structural brain antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875690      PMCID: PMC1028453          DOI: 10.1136/jnnp.48.8.807

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Multiple sclerosis: local synthesis of electrophoretically restricted measles, rubella, mumps and herpes simplex virus antibodies in the central nervous system.

Authors:  H J Nordal; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Myelination in rat brain: changes in myelin composition during brain maturation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

4.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; R C Shortman; P Rudge; W I McDonald
Journal:  Br Med J       Date:  1979-01-06

5.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

6.  Migrainous phenomena in systemic lupus erythematosus.

Authors:  K D Brandt; S Lessell
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

7.  Systemic lupus erythematosus. A prospective analysis.

Authors:  R Grigor; J Edmonds; R Lewkonia; B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

8.  Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2.

Authors:  M Kadlubowski; R A Hughes; N A Gregson
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

9.  Antibodies to viral and non-viral antigens in subacute sclerosing panencephalitis and multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing, antigen immunofixation and autoradiography.

Authors:  J Shorr; B Roström; H Link
Journal:  J Neurol Sci       Date:  1981-01       Impact factor: 3.181

10.  IgM and IgG responses during chronic relapsing experimental allergic encephalomyelitis (r-EAE).

Authors:  T Olsson; A Henriksson; H Link; K Kristensson
Journal:  J Neuroimmunol       Date:  1984-07       Impact factor: 3.478

View more
  12 in total

Review 1.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

2.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

3.  The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases.

Authors:  M Haertle; U Kallweit; M Weller; M Linnebank
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

4.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

5.  Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis.

Authors:  N Mavroudakis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

6.  Systemic lupus erythematosus presenting with neurological disorders.

Authors:  M R Tola; E Granieri; L Caniatti; E Paolino; C Monetti; L Dovigo; R Scolozzi; P De Bastiani; M Carreras
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

7.  Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy.

Authors:  B R Kaye; C M Neuwelt; S S London; S J DeArmond
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

Review 8.  Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction.

Authors:  P M Moore; R P Lisak
Journal:  Springer Semin Immunopathol       Date:  1995

9.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

10.  Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.

Authors:  Estelle Trysberg; Kina Höglund; Elisabet Svenungsson; Kaj Blennow; Andrej Tarkowski
Journal:  Arthritis Res Ther       Date:  2004-01-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.